1373216-45-5

This ADC product is composed of an anti-CEACAM5 antibody conjuagated via a CL1 linker to SN-38 (CL1-SN-38). It has demonstrated a response in colon carcinoma treatment by a MOA (Mechanism of Action) of Inhibit Topoisomerase I and cause DNA damage.